Albert Bourla, the Pfizer CEO behind the lifesaving COVID vaccine, received the $1m Genesis Prize from Israeli President Isaac Herzog on Wednesday. Dr Bourla, 60, said he was donating the entire sum towards establishing a holocaust museum in Greece, where his parents were among the 2,000 Jews from Thessaloniki who survived. The Genesis Prize is […]

CytoReason built a machine learning platform that can quantify a person’s immune system in order to better understand disease responses.

Researchers from the University of Haifa said that women reported 1.9 times as many side effects as men after receiving the Pfizer vaccine.

Genesis Prize Foundation recognized Bourla for leading Pfizer's efforts to develop the COVID-19 vaccine and his willingness to take risks.

AION Labs, is a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science

Top US health official Dr. Anthony Fauci says Israel to soon have more information on myocarditis, an inflammation of the heart in younger males.

Israeli AI company Cytoreason develops computational disease models of the human immune system for discovery and clinical drug development.

Early research shows the vaccine triggers an antibody response in breastmilk, potentially contributing to the protection of breastfed babies.

The innovation lab, which will also include pharma companies Merck, and Teva, will research digital health and computational biology.

Founded in 2016, CytoReason already has partnerships with top global pharmaceutical companies.

The company's propriety platform combines scientific and experimental data for immune system simulations applicable to cancer immunotherapy, and autoimmune, neurodegenerative and infectious disease research.

December 28, 2016 | DIR Technologies, which is developing quality control devices for the pharmaceutical industry, will receive a $10 million investment from pharmaceutical giant Pfizer under a strategic cooperation agreement. DIR’s products inform users whether a small bottle or package of drugs is properly sealed when it leaves the factory. The usual method of […]

Israeli research showing that Pfizer’s blockbuster erectile-function medication Viagra can cause risky side effects in men who have had a stroke have induced Wolfson Medical Center researchers to determine whether the competing drug, GlaxoSmithKline’s Cialis, has the same effect.